Psychemedics Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 6.51 million compared to USD 6.09 million a year ago. Net loss was USD 0.338 million compared to net income of USD 0.134 million a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to diluted earnings per share from continuing operations of USD 0.02 a year ago.
For the six months, sales was USD 13.02 million compared to USD 11.8 million a year ago. Net loss was USD 0.299 million compared to net income of USD 0.217 million a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.